Molecular Population Genetics of Human CYP3A Locus: Signatures of Positive Selection and Implications for Evolutionary Environmental Medicine

Background The human CYP3A gene cluster codes for cytochrome P450 (CYP) subfamily enzymes that catalyze the metabolism of various exogenous and endogenous chemicals and is an obvious candidate for evolutionary and environmental genomic study. Functional variants in the CYP3A locus may have undergone a selective sweep in response to various environmental conditions. Objective The goal of this study was to profile the allelic structure across the human CYP3A locus and investigate natural selection on that locus. Methods From the CYP3A locus spanning 231 kb, we resequenced 54 genomic DNA fragments (a total of 43,675 bases) spanning four genes (CYP3A4, CYP3A5, CYP3A7, and CYP3A43) and two pseudogenes (CYP3AP1 and CYP3AP2), and randomly selected intergenic regions at the CYP3A locus in Africans (24 individuals), Caucasians (24 individuals), and Chinese (29 individuals). We comprehensively investigated the nucleotide diversity and haplotype structure and examined the possible role of natural selection in shaping the sequence variation throughout the gene cluster. Results Neutrality tests with Tajima’s D, Fu and Li’s D* and F*, and Fay and Wu’s H indicated possible roles of positive selection on the entire CYP3A locus in non-Africans. Sliding-window analyses of nucleotide diversity and frequency spectrum, as well as haplotype diversity and phylogenetically inferred haplotype structure, revealed that CYP3A4 and CYP3A7 had recently undergone or were undergoing a selective sweep in all three populations, whereas CYP3A43 and CYP3A5 were undergoing a selective sweep in non-Africans and Caucasians, respectively. Conclusion The refined allelic architecture and selection spectrum for the human CYP3A locus highlight that evolutionary dynamics of molecular adaptation may underlie the phenotypic variation of the xenobiotic disposition system and varied predisposition to complex disorders in which xenobiotics play a role.

[1]  A. Schinkel,et al.  Intestinal cytochrome P450 3A plays an important role in the regulation of detoxifying systems in the liver , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  Fengtang Yang,et al.  Adaptive evolution of UGT2B17 copy-number variation. , 2008, American journal of human genetics.

[3]  C. Masimirembwa,et al.  Prediction of sites under adaptive evolution in cytochrome P450 sequences and their relationship to substrate recognition sites , 2008, Pharmacogenetics and genomics.

[4]  Matthias Platzer,et al.  CYP3 phylogenomics: evidence for positive selection of CYP3A4 and CYP3A7 , 2008, Pharmacogenetics and genomics.

[5]  Pardis C Sabeti,et al.  Genome-wide detection and characterization of positive selection in human populations , 2007, Nature.

[6]  M. Shimizu,et al.  Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3) , 2007, Pharmacogenetics and genomics.

[7]  F. He,et al.  Comparative and evolutionary pharmacogenetics of ABCB1: complex signatures of positive selection on coding and regulatory regions , 2007, Pharmacogenetics and genomics.

[8]  Shufeng Zhou,et al.  Metabolic activation of herbal and dietary constituents and its clinical and toxicological implications: an update. , 2007, Current drug metabolism.

[9]  Natasha T. Snider,et al.  Anandamide Metabolism by Human Liver and Kidney Microsomal Cytochrome P450 Enzymes to Form Hydroxyeicosatetraenoic and Epoxyeicosatrienoic Acid Ethanolamides , 2007, Journal of Pharmacology and Experimental Therapeutics.

[10]  Pardis C Sabeti,et al.  Deciphering the ancient and complex evolutionary history of human arylamine N-acetyltransferase genes. , 2006, American journal of human genetics.

[11]  M. Haberl,et al.  Genetic signature consistent with selection against the CYP3A4*1B allele in non-African populations , 2006, Pharmacogenetics and genomics.

[12]  R. Hudson,et al.  An evolutionary framework for common diseases: the ancestral-susceptibility model. , 2005, Trends in genetics : TIG.

[13]  A. Gaedigk,et al.  Variability of CYP3A7 Expression in Human Fetal Liver , 2005, Journal of Pharmacology and Experimental Therapeutics.

[14]  K. Tang,et al.  A functional polymorphism within the MRP1 gene locus identified through its genomic signature of positive selection. , 2005, Human molecular genetics.

[15]  M. Ingelman-Sundberg,et al.  Identification and Phenotype Characterization of Two CYP3A Haplotypes Causing Different Enzymatic Capacity in Fetal Livers , 2005, Clinical pharmacology and therapeutics.

[16]  B. Blumberg,et al.  Steroid and xenobiotic receptor (SXR), cytochrome P450 3A4 and multidrug resistance gene 1 in human adult and fetal tissues , 2005, Molecular and Cellular Endocrinology.

[17]  David B. Witonsky,et al.  CYP3A variation and the evolution of salt-sensitivity variants. , 2004, American journal of human genetics.

[18]  A. Weston,et al.  CYP3A4 polymorphisms--potential risk factors for breast and prostate cancer: a HuGE review. , 2004, American journal of epidemiology.

[19]  M. Nachman,et al.  Genome scans of DNA variability in humans reveal evidence for selective sweeps outside of Africa. , 2004, Molecular biology and evolution.

[20]  Kun Tang,et al.  Genomic evidence for recent positive selection at the human MDR1 gene locus. , 2004, Human molecular genetics.

[21]  L. Wojnowski.  Genetics of the variable expression of CYP3A in humans. , 2004, Therapeutic drug monitoring.

[22]  Xavier Messeguer,et al.  DnaSP, DNA polymorphism analyses by the coalescent and other methods , 2003, Bioinform..

[23]  Yan Shen,et al.  LDA - a java-based linkage disequilibrium analyzer , 2003, Bioinform..

[24]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[25]  A. Conney,et al.  Human cytochrome P450 3A7 has a distinct high catalytic activity for the 16alpha-hydroxylation of estrone but not 17beta-estradiol. , 2003, Cancer research.

[26]  P. Watkins,et al.  CYP3A5 genotype predicts renal CYP3A activity and blood pressure in healthy adults. , 2003, Journal of applied physiology.

[27]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Kun Zhang,et al.  HaploBlockFinder: Haplotype Block Analyses , 2003, Bioinform..

[29]  J. Dorne,et al.  Human variability in CYP3A4 metabolism and CYP3A4-related uncertainty factors for risk assessment. , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[30]  M. Bamshad,et al.  Signatures of natural selection in the human genome , 2003, Nature Reviews Genetics.

[31]  W S Watkins,et al.  DNA sequence variation in a 3.7-kb noncoding sequence 5' of the CYP1A2 gene: implications for human population history and natural selection. , 2002, American journal of human genetics.

[32]  H. Glaeser,et al.  Molecular Mechanisms of Polymorphic CYP3A7 Expression in Adult Human Liver and Intestine* , 2002, The Journal of Biological Chemistry.

[33]  Carsten Schwarz,et al.  Genomewide comparison of DNA sequences between humans and chimpanzees. , 2002, American journal of human genetics.

[34]  K. Kidd,et al.  Geographic and haplotype structure of candidate type 2 diabetes susceptibility variants at the calpain-10 locus. , 2002, American journal of human genetics.

[35]  G. Chabot,et al.  Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids. , 2002, Biochemical pharmacology.

[36]  J. Stephens,et al.  Haplotype Variation and Linkage Disequilibrium in 313 Human Genes , 2001, Science.

[37]  B. M. Forman,et al.  The orphan nuclear receptor SXR coordinately regulates drug metabolism and efflux , 2001, Nature Medicine.

[38]  J. Halpert,et al.  Influence of P450 3A4 SRS-2 residues on cooperativity and/or regioselectivity of aflatoxin B(1) oxidation. , 2001, Chemical research in toxicology.

[39]  Ann Daly,et al.  Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression , 2001, Nature Genetics.

[40]  U. Brinkmann,et al.  Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. , 2001, Pharmacogenetics.

[41]  M. Daly,et al.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.

[42]  P. Zaphiropoulos,et al.  The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. , 2000, Gene.

[43]  B. Su,et al.  Natives or immigrants: modern human origin in east asia , 2000, Nature Reviews Genetics.

[44]  J. Phillips,et al.  CYP3A-inducing agents and the attenuation of uroporphyrin accumulation and excretion in a rat model of porphyria cutanea tarda. , 2000, Biochemical pharmacology.

[45]  D. Nebert,et al.  The Evolution of Drug Metabolism , 2000, Pharmacology.

[46]  M. Nachman,et al.  Contrasting evolutionary histories of two introns of the duchenne muscular dystrophy gene, Dmd, in humans. , 2000, Genetics.

[47]  Justin C. Fay,et al.  Hitchhiking under positive Darwinian selection. , 2000, Genetics.

[48]  Gonçalo R. Abecasis,et al.  GOLD-Graphical Overview of Linkage Disequilibrium , 2000, Bioinform..

[49]  L. Jin,et al.  Genetic relationship of populations in China. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Hosokawa,et al.  Differential catalytic properties in metabolism of endogenous and exogenous substrates among CYP3A enzymes expressed in COS-7 cells. , 1998, Biochimica et biophysica acta.

[51]  J. Schuetz,et al.  Identification of the fetal liver cytochrome CYP3A7 in human endometrium and placenta. , 1993, The Journal of clinical investigation.

[52]  W. Li,et al.  Statistical tests of neutrality of mutations. , 1993, Genetics.

[53]  K K Kidd,et al.  Drift, admixture, and selection in human evolution: a study with DNA polymorphisms. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[54]  Richard R. Hudson,et al.  The coalescent process in models with selection, recombination and geographic subdivision. , 1991, Genetical research.

[55]  F. Tajima.  Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. , 1989, Genetics.

[56]  B. Weir,et al.  ESTIMATING F‐STATISTICS FOR THE ANALYSIS OF POPULATION STRUCTURE , 1984, Evolution; international journal of organic evolution.

[57]  G. A. Watterson.  On the number of segregating sites in genetical models without recombination. , 1975, Theoretical population biology.

[58]  P. Siiteri,et al.  The utilization of circulating dehydroisoandrosterone sulfate for estrogen synthesis during human pregnancy , 1963 .

[59]  A. Gaedigk,et al.  Variability of CYP 3 A 7 Expression in Human Fetal Liver , 2005 .

[60]  Ken-Ichi Fujita.  FOOD-DRUG INTERACTIONS VIA HUMAN CYTOCHROME P450 3A (CYP3A) , 2004, Drug metabolism and drug interactions.

[61]  A. Conney,et al.  Human Cytochrome P450 3A7 Has a Distinct High Catalytic Activity for the 16 -Hydroxylation of Estrone but not 17 -Estradiol , 2003 .

[62]  John D. Storey,et al.  Statistical Significance for Genome-Wide Studies , 2003 .

[63]  H. Bandelt,et al.  Median-joining networks for inferring intraspecific phylogenies. , 1999, Molecular biology and evolution.